EMEA News
The manufacturer of the electronic artificial urinary sphincter aims to develop its device for treating urinary incontinence.
The technology release launches the delayed MedTech Funding Mandate that accelerates uptake of innovative treatments and therapies.
The company first collaborated with HSE on a pilot programme for psychological services in 2018.
The funds will be used to develop the firm’s non-invasive blood sensing technology.
The sterilisation method has been used in hospitals and laboratories for more than 50 years.
System which identifies patients at risk of fatal heart attack obtains CE mark.
Hayat-Vax is a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42. Meanwhile, the country’s COVID-19 contact tracing app will now also function as a national vaccine registry.
Private bookings for a COVID-19 vaccine start from AED 1,300 (approx. $354).
The new algorithm allows for automated analysis of CT scans of patients with the condition.
Concerns raised that EU Health Technology Assessment Regulation could lead to delays in market approval.